Drug Development, Health Policy and Strategy

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Drug Development

Health Policy

Strategy

Healthcare AI investment will shift to these 5 areas in the next 2 years: survey

Henry Kotula

MARCH 10, 2021

At life sciences companies, AI is primarily deployed during the drug development process to improve record-keeping and the application process, the survey found. Clinical trials and diagnosis rounded out the top five investment areas. Companies also have leveraged AI to help with clinical trial site selection.

Life Science

Life Science Pharmaceuticals Drug Development EHR

BCG Vaccine Shows Promising Signals of T1D Efficacy

Insulin Nation

FEBRUARY 7, 2019

We found in human and mouse research that defects in white blood cells causing disease had a signaling pathway that we could drug. False positives are inconvenient, and public health policy changed overtime to stop recommending BCG vaccine in Europe. Again, money always drives these generic drug development steps.

Drug Development

Drug Development Health Policy Public Health

Connected Health Pulse

Healthcare AI investment will shift to these 5 areas in the next 2 years: survey

BCG Vaccine Shows Promising Signals of T1D Efficacy

Stay Connected